Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CHIMERA: A Phase II Study of Neoadjuvant Pembrolizumab in Combination With Cisplatin or Carboplatin and Pemetrexed Followed by Surgery and Adjuvant Pembrolizumab in Resectable Pleural Mesothelioma.

Clinical lung cancer·2026
Same author

Development of a Radiologic Nomogram to Predict Invasiveness in Pulmonary Pure Ground-Glass Opacities: Analysis of the GORDON Cohort.

Cancers·2026
Same author

Use of a composite, 3D-printed patch as a partial airway replacement: A pilot study on the porcine model.

Bioengineering & translational medicine·2026
Same author

Surgery for Benign Tracheoesophageal Fistula: Analysis of Short- and Long-Term Outcomes.

World journal of surgery·2026
Same author

Video-assisted thoracoscopic surgery as redo approach after prior open lobectomy: is it safely feasible?-challenges and pitfalls of a complex surgical technique.

Journal of visualized surgery·2026
Same author

Editorial: Exploring the tumor microenvironment in resectable lung cancer.

Frontiers in oncology·2026

Related Experiment Video

Updated: Jul 13, 2026

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

Valsalva prosthesis in aortic valve-sparing operations.

Roberto Di Bartolomeo1, Davide Pacini, Sofia Martin-Suarez

  • 1Department of Cardiac Surgery, S.Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

Interactive Cardiovascular and Thoracic Surgery
|August 3, 2007
PubMed
Summary

The Gelweave Valsalva prosthesis aids aortic valve-sparing surgery by creating neo-sinuses, potentially improving valve durability. Long-term studies are needed to confirm reduced leaflet deterioration in patients undergoing aortic root repair.

More Related Videos

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

Related Experiment Videos

Last Updated: Jul 13, 2026

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

Area of Science:

  • Cardiovascular Surgery
  • Thoracic Surgery
  • Aortic Surgery

Background:

  • Aortic valve-sparing operations offer good clinical outcomes but may face challenges with valve durability due to the absence of sinuses of Valsalva.
  • The Gelweave Valsalva prosthesis was developed with pre-fashioned neo-sinuses to mitigate early leaflet deterioration.

Purpose of the Study:

  • To evaluate the clinical outcomes and durability of aortic valve-sparing reimplantation using the Gelweave Valsalva prosthesis.
  • To assess the efficacy of the Gelweave Valsalva graft in preventing leaflet deterioration and the need for reoperation.

Main Methods:

  • A retrospective analysis of 63 patients undergoing aortic valve-sparing reimplantation with the Gelweave Valsalva graft.
  • Indications included ascending aorta aneurysm, annuloaortic ectasia, Marfan syndrome, Bicuspid Aortic Valve (BAV), and acute Type A dissection.

Main Results:

  • In-hospital mortality was 4.7%, primarily in acute Type A dissection patients (P=0.01).
  • No late deaths were reported.
  • Three-year freedom from grade 3-4 aortic insufficiency (AI) was 91.7+/-4.3%, and freedom from late aortic valve replacement was 93.8+/-5.1%.

Conclusions:

  • Aortic valve-sparing operations demonstrate favorable results for elective aortic root ectasia repair.
  • While the Gelweave Valsalva prosthesis is technically straightforward and replicates pseudosinuses, long-term follow-up is essential.
  • Further investigation is required to ascertain if this prosthesis effectively reduces leaflet deterioration over time.